Worldwide, there are over one billion people who suffer from depression, anxiety, PTSD, and addiction and this has created an industry within the pharmaceutical world that is extremely lucrative, but ripe for disruption. The global mental health market is expected to reach $6 trillion by 2030 and there are now...
Psychedelic Compound Drug Stocks DOWN 16% In August – Here’s Why
An Introduction The psychedelic compound-based drug market is expected to triple over the next few years which should create many winning stocks in the years to come. By Lorimer Wilson Some Background Shares of clinical-stage companies developing treatments based on psychedelic compound-based drugs moved lower in early August after the...